# reload+after+2024-01-23 00:37:57.195618
address1§1 Springbank Road
address2§Springbank Industrial Estate Dunmurry
city§Belfast
zip§BT17 0QL
country§United Kingdom
phone§44 28 9043 2800
website§https://www.fusionantibodies.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. The company was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
fullTimeEmployees§48
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Adrian Robert Kinkaid Ph.D.', 'age': 56, 'title': 'CEO & Director', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 183490, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Richard John Buick Ph.D.', 'age': 47, 'title': 'Chief Scientific Officer & Director', 'yearBorn': 1976, 'fiscalYear': 2023, 'totalPay': 127000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Jim  Johnston', 'title': 'Founder', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen Barry Smyth', 'age': 48, 'title': 'Company Secretary, Interim CFO & Director', 'yearBorn': 1975, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nicola  Hamilton', 'title': 'Operations Manager', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Paul Gerard Kerr', 'age': 50, 'title': 'Consultant', 'yearBorn': 1973, 'fiscalYear': 2023, 'totalPay': 180385, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.575
priceToSalesTrailing12Months§1.6002419
currency§GBp
forwardEps§-2.5
exchange§LSE
quoteType§EQUITY
shortName§FUSION ANTIBODIES PLC ORD 4P
longName§Fusion Antibodies plc
firstTradeDateEpochUtc§1513584000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§bd808fc4-a2ac-3951-877a-20afc7a6e03e
recommendationKey§none
quickRatio§2.318
grossMargins§-0.074099995
ebitdaMargins§-1.7726401
trailingPegRatio§None
